XASE · CCEL
+4.56% · +$0.1900 · Vol 5.5K
After hours · updated 16:10:00 ET
Cryo-Cell International Inc.

Cryo-Cell International Inc.

SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
$4.36
Card
Relationship Map

Follow $CCEL

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $CCEL by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology

snapshot unavailable for CCEL. Cause unavailable.

Sentiment absence reason unknown
CCEL
Cryo-Cell International Inc.
Stale score · Thu Oct 8 · completed session · 23h old · Scheduled each trading day · Markets closed · resumes Mon 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

51/ 100
Veridion Score
Middle range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 5 of 6 factors measured · Stale score · Thu Oct 8 · completed session · 23h old · Scheduled each trading day · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CCEL moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CCEL catalysts
About Cryo-Cell International Inc.
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Employees
76
Country
US

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.00
Day high
$4.47
Day low
$4.00
Previous close
$4.17
52W high
$4.57
-4.60% from high
52W low
$2.89
88% of range
Market cap
$33.6M
Beta
0.70
Shares out
8.1M
Volume
5.5K
0.41× rel vol
Avg volume
13.5K
VWAP
$4.19
Price history computed in-house
1W
+9.27%
1M
+6.08%
3M
+27.49%
1Y
-1.36%
YTD
+26.75%
SMA 50 $4.03 · above
SMA 200 $3.59 · above
52W position 88%

CCEL overview

Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file
Loading financial statements
Loading CCEL Form 4 filings
Public disclosures

Congress activity in CCEL

No receipt-qualified filings found.

Federal contracts

CCEL contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CCEL in this window.
Lobbying spend

CCEL lobbying filings, year to date.

Registered lobbying filings matched to Cryo-Cell International Inc..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CCEL in this window.
Loading news for CCEL
Analyst ratings
Sovereign unlock shows live analyst consensus for CCEL.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.